[Neurology].

[Neurology].

Rev Med Suisse. 2016 Jan 13;12(500):62, 64-6

Authors: Sokolov AA, Rossetti AO, Michel P, Benninger D, Nater B, Wider C, Hirt L, Kuntzer T, Démonet JF, Du Pasquier RA, Vingerhoets F

Abstract
In 2015, cerebral stimulation becomes increasingly established in the treatment of pharmacoresistant epilepsy. Efficacy of endovascular treatment has been demonstrated for acute ischemic stroke. Deep brain stimulation at low frequency improves dysphagia and freezing of gait in Parkinson patients. Bimagrumab seems to increase muscular volume and force in patients with inclusion body myositis. In cluster-type headache, a transcutaneous vagal nerve stimulator is efficient in stopping acute attacks and also reducing their frequency. Initial steps have been undertaken towards modulating memory by stimulation of the proximal fornix. Teriflunomide is the first oral immunomodulatory drug for which efficacy has been shown in preventing conversion from clinical isolated syndrome to multiple sclerosis.

PMID: 26946707 [PubMed - in process]

from #ENT via xlomafota13 on Inoreader http://ift.tt/1U1h0DG
via IFTTT